JAMA Neurology on Mythryl: “Randomized clinical trial indicates middle meningeal artery…”

Randomized clinical trial indicates middle meningeal artery embolization with n-butyl cyanoacrylate plus standard care reduced #SubduralHematoma recurrence and need for surgery vs standard care alone, with comparable safety profile. ja.ma/4q0MJYA

ja.maMiddle Meningeal Artery Embolization With n-Butyl Cyanoacrylate in Chronic Subdural HematomaThis randomized clinical trial evaluates whether n-butyl cyanoacrylate for middle meningeal artery embolization plus standard of care reduces the residual or re-accumulation of hematoma compared with standard of care alone.

14/8/26, 1:00 pm0 reposts0 likes

Post